We chat with Adam Stoten, the chief operating officer of Oxford University Innovation, about vaccines – not just for covid but also one for tuberculosis he helped develop at a spinout – as well as the importance of REF, KEF and the Knowledge Exchange Concordat, and the success of LAB282. He also exclusively reveals what is next for him personally.

<a href="http://creativecommons.org/licenses/by/3.0/" target="_blank" rel="noreferrer noopener">&#8220;Funk Game Loop&#8221; Kevin MacLeod (incompetech.com)</a>
<a href="http://creativecommons.org/licenses/by/3.0/" target="_blank" rel="noreferrer noopener">Licensed under Creative Commons: By Attribution 3.0</a>

Markus Wanko: Institute of Science and Technology Austria

Beyond the Breakthrough is a weekly interview show with the brightest minds in university innovation tackling the question: how does research get from a lab into the marketplace? It is hosted by Thierry Heles.